ARTL

$0.00

(

0.00%

)
Quote details

stock

Artelo Biosciences Inc

NASDAQ | ARTL

1.71

USD

$0.00

(

0.00%

)

At Close (As of Dec 3, 2025)

$3.51M

Market Cap

-

P/E Ratio

-19.5

EPS

$28.60

52 Week High

$1.52

52 Week Low

HEALTHCARE

Sector

ARTL Chart

Recent Chart
Price Action

ARTL Technicals

Tags:

ARTL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

Revenue & Profitability

Earnings Performance

ARTL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.7M
Total Current Assets $2.6M
Cash And Cash Equivalents At Carrying Value $2.3M
Cash And Short Term Investments $2.3M
Inventory -
Current Net Receivables -
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2M
Intangible Assets Excluding Goodwill $2M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $219K
Other Non Current Assets -
Total Liabilities $1.8M
Total Current Liabilities $1.8M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $35K
Total Non Current Liabilities $69K
Capital Lease Obligations $104K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $104K
Other Current Liabilities $58K
Other Non Current Liabilities -
Total Shareholder Equity $2.9M
Treasury Stock -
Retained Earnings -$50M
Common Stock $3K
Common Stock Shares Outstanding $3.2M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$8.4M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $7.8M
Cashflow From Financing $112K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

ARTL News

ARTL Profile

Artelo Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Artelo Biosciences Inc. (ARTL), headquartered in La Jolla, California, is a clinical-stage biopharmaceutical firm focused on developing innovative therapies that utilize the endocannabinoid system to tackle a range of medical challenges. The company aims to enhance cannabinoid efficacy through its diverse pipeline, which primarily targets oncology, pain management, and appetite stimulation. With a commitment to scientific rigor and compliance with regulatory standards, Artelo is poised to address significant unmet needs in the cannabinoid therapeutics sector, presenting a compelling opportunity for institutional investors seeking growth in the biopharmaceutical space.

LPTX
+368.57%
$2.05
PAVS
-37.38%
$0.03
VRAX
+37.97%
$0.54
IXHL
+16.01%
$0.46
IRBT
+74.87%
$3.41
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.23%
$181.04
ONDS
-1.47%
$7.95
IPG
-1.95%
$24.57
NIO
-5.76%
$4.74
AXDX
-61.36%
$0.03
PLUG
+3.08%
$2.17
TSLA
+4.23%
$447.43
KITT
+53.62%
$1.11
BYND
-7.01%
$1.19
BITF
-1.77%
$3.04
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
INTC
+0.21%
$43.56
RR
+11.93%
$3.98
QCLS
+38.16%
$4.67
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
MRVL
+6.22%
$98.67
BMNR
+3.68%
$33.08
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
AAL
+1.79%
$14.49
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
BBD
-2.45%
$3.58
T
-1.04%
$25.52
PFE
+1.89%
$25.62
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
MTSR
-0.35%
$70.50
F
+1.19%
$13.11
PLTD
-2.01%
$6.81
AEO
+13.53%
$23.64
VICI
-0.48%
$28.45
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
AAPL
-0.28%
$285.36
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
AMZN
-1.07%
$231.89
RIOT
-1.67%
$15.22
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
ASBP
-8.60%
$0.09
GOOGL
+1.58%
$320.82
CLSK
+3.17%
$14.14
PMAX
+24.22%
$2.82
CHR
-5.80%
$0.04
PLTR
+2.06%
$174.21
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
MSFT
-1.60%
$482.11
CMND
-12.88%
$0.11
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
PCG
-1.01%
$15.16
HOOD
+5.39%
$132.74
JOBY
+2.67%
$13.83
RIG
+3.03%
$4.44
PYPL
-2.46%
$61.35
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
BMY
+5.66%
$50.98
PSTG
-27.13%
$69.02
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
CRCL
+7.27%
$83.07
CAN
-1.26%
$0.95
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
GRAB
-0.76%
$5.22
DVLT
-4.79%
$1.78
SAND
-6.04%
$12.12
GPUS
-5.64%
$0.27
SHOT
-74.37%
$0.39
LPTX
+368.57%
$2.05
PAVS
-37.38%
$0.03
VRAX
+37.97%
$0.54
IXHL
+16.01%
$0.46
IRBT
+74.87%
$3.41
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.23%
$181.04
ONDS
-1.47%
$7.95
IPG
-1.95%
$24.57
NIO
-5.76%
$4.74
AXDX
-61.36%
$0.03
PLUG
+3.08%
$2.17
TSLA
+4.23%
$447.43
KITT
+53.62%
$1.11
BYND
-7.01%
$1.19
BITF
-1.77%
$3.04
ADAP
-15.14%
$0.05
ASST
-2.41%
$1.01
INTC
+0.21%
$43.56
RR
+11.93%
$3.98
QCLS
+38.16%
$4.67
IREN
+7.36%
$44.15
CAPR
+385.06%
$30.85
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
MRVL
+6.22%
$98.67
BMNR
+3.68%
$33.08
INHD
-7.67%
$0.13
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
AAL
+1.79%
$14.49
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
BBD
-2.45%
$3.58
T
-1.04%
$25.52
PFE
+1.89%
$25.62
VALE
+1.57%
$12.89
WLGS
-5.57%
$0.04
SOFI
+0.44%
$29.64
MTSR
-0.35%
$70.50
F
+1.19%
$13.11
PLTD
-2.01%
$6.81
AEO
+13.53%
$23.64
VICI
-0.48%
$28.45
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
ACHR
+4.37%
$7.98
MARA
+2.97%
$12.26
AAPL
-0.28%
$285.36
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
AMZN
-1.07%
$231.89
RIOT
-1.67%
$15.22
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
ASBP
-8.60%
$0.09
GOOGL
+1.58%
$320.82
CLSK
+3.17%
$14.14
PMAX
+24.22%
$2.82
CHR
-5.80%
$0.04
PLTR
+2.06%
$174.21
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
MSFT
-1.60%
$482.11
CMND
-12.88%
$0.11
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
PCG
-1.01%
$15.16
HOOD
+5.39%
$132.74
JOBY
+2.67%
$13.83
RIG
+3.03%
$4.44
PYPL
-2.46%
$61.35
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
BMY
+5.66%
$50.98
PSTG
-27.13%
$69.02
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
BTG
+0.81%
$4.46
MSTR
+2.68%
$186.20
CRCL
+7.27%
$83.07
CAN
-1.26%
$0.95
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
GRAB
-0.76%
$5.22
DVLT
-4.79%
$1.78
SAND
-6.04%
$12.12
GPUS
-5.64%
$0.27
SHOT
-74.37%
$0.39

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.